Magnesium as a Mediator of Bone and Vitamin D Metabolism in Patients on Antiepileptic Drug Therapy

Stopped early

Conditions studied: Epilepsy, Magnesium Deficiency, Vitamin D Deficiency

In brief

The objective of this study is to determine the role of magnesium on bone and vitamin D metabolism in patients receiving anti-epileptic medications.

Key facts

Study ID

NCT03471481

Run by

Drexel University

People needed

7

Starts

2015-08-10

Expected to finish

2019-08-01

Last updated by the study team

2021-03-01

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Individuals receiving anti-epileptic drugs as a treatment for epilepsy

You may not qualify if…

• Individuals who are pregnant or breastfeeding, receiving cancer treatments, have liver or kidney diseases, autoimmune diseases, or other diseases that may interfere with vitamin D and magnesium metabolism.

Where it is running

• Drexel University Nutrition Sciences Research Lab — Philadelphia, Pennsylvania, United States
• Drexel University — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.